Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy
- 1 May 2004
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 40 (5) , 815-822
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Liver transplantation for primary sclerosing cholangitis in the Nordic countries: Outcome after acceptance to the waiting listLiver Transplantation, 2003
- Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control studyJournal of Hepatology, 2001
- Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinomaLiver Transplantation, 2000
- Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitisJournal of Gastrointestinal Surgery, 1999
- Prevention of N‐Methylnitrosourea‐induced Colon Tumorigenesis by Ursodeoxycholic Acid in F344 RatsJapanese Journal of Cancer Research, 1998
- Different bile acids exhibit distinct biological effects: The tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferationNutrition and Cancer, 1998
- Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantationSurgery, 1995
- Primary sclerosing cholangitis: Liver transplantation or biliary surgerySurgery, 1995
- Is liver transplantation indicated for cholangiocarcinoma?The American Journal of Surgery, 1993
- Selection and Timing of Liver Transplantation in Primary Biliary Cirrhosis and Primary Sclerosing CholangitisHepatology, 1992